11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection [Rituxan Hycela]
RxNorm concept 1927890, branded drug (sbd). Prescribable name: Rituxan Hycela 1400 MG / 23,400 UNT in 11.7 ML Injection.
- RxCUI
- 1927890
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1927890 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / riTUXimab 120 MG/ML Injection [Rituxan Hycela]; Rituxan Hycela 1400 MG / 23,400 UNT per 11.7 ML Injection
Related concepts
- hyaluronidase, human recombinant 2000 UNT/ML (SCDC, consists of)
- rituximab 120 MG/ML (SCDC, consists of)
- hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML [Rituxan Hycela] (SBDC, consists of)
- Injection (DF, has dose form)
- Rituxan Hycela (BN, has ingredient)
- 11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1927890 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1927890 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1927890. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.